PFE

Pfizer, Inc.

52.43
USD
2.93%
52.43
USD
2.93%
38.93 61.71
52 weeks
52 weeks

Mkt Cap 292.46B

Shares Out 5.58B

Chat
Send me real-time posts from this site at my email

S Market Selloff

In a U.S. market selloff, the strong performance of mostly foreign issues was impressive. Of course, with our own foreign bias, we are looking good. Our global picks are upwardly mobile: *CTRA, the fold miner, is now a buy with a $1.101 target price; *ESTE with a $.939 TP. *Banco Latino with a $.49 TP; BLX *ZYME with a new estimate of $.869 up despite it being lower. *Organon with a new buy rating and a TO of $1.4. OGN. *Pfizer with a new buy rating and a TP of $2.03 up from $1.97. PFE. *CIR with a new buy rating and a TP of $1.97 vs $.379. *And Nutrien with $5.96 up from 5.91 (US). NTR. *Roche is partnering with AUM to test its non-small cell lung cancer and utrothelian cancer drug. RHHBY. *Noble Energy NE plans to sell its UK jack-up rigs to support competition and is now as rated buy by Carl Suvran.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue